Inventor
DE SAUVAGE FREDERIC J
US36 patents
⚠️ This page may combine multiple inventors who share the name “DE SAUVAGE FREDERIC J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
22 patentsUS7888478B2Feb 15, 2011
Compositions and methods for the treatment of tumor of hematopoietic origin
GENENTECH INC15 citations92
US7303896B2Dec 4, 2007
Nucleic acid encoding novel type-1 cytokine receptor GLM-R
GENENTECH INC38 citations91
US6136958AOct 24, 2000
Antibodies to vertebrate smoothened proteins
GENENTECH INC16 citations91
US7393532B1Jul 1, 2008
Modulation of T cell differentiation for the treatment of T helper cell mediated diseases
GENENTECH INC13 citations83
US7026138B1Apr 11, 2006
Polynucleotides encoding GFRα3
GENENTECH INC16 citations83
US7858330B2Dec 28, 2010
Compositions and methods for the treatment of tumor of hematopoietic origin
GENENTECH INC15 citations82
US7754441B2Jul 13, 2010
Compositions and methods for the treatment of tumor of hematopoietic origin
GENENTECH INC10 citations82
US7931902B2Apr 26, 2011
Gene disruptions, compositions and methods relating thereto
GENENTECH INC11 citations79
US5830647ANov 3, 1998
Hybridization and amplification of nucleic acids encoding mpl ligand
GENENTECH INC13 citations74
US7691973B2Apr 6, 2010
GFRα3 polypeptides
GENENTECH INC7 citations73
US7625759B2Dec 1, 2009
Method for using BOC/CDO to modulate hedgehog signaling
GENENTECH INC5 citations73
US6492139B1Dec 10, 2002
Vertebrate smoothened proteins
GENENTECH INC5 citations72
US5990281ANov 23, 1999
Vertebrate smoothened proteins
GENENTECH INC8 citations72
US9096686B2Aug 4, 2015
E518A/K mutant smoothened and methods of using the same
GENENTECH INC3 citations60
US7858843B2Dec 28, 2010
Gene disruptions, compositions and methods relating thereto
GENENTECH INC4 citations57
US8357513B1Jan 22, 2013
Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
GENENTECH INC0 citations52
US6660256B1Dec 9, 2003
Porcine mpl ligand
GENENTECH INC1 citations52
US7811777B2Oct 12, 2010
Methods of screening for agonists and antagonists of patched-2
GENENTECH INC0 citations51
US7579161B2Aug 25, 2009
Assay methods for suppressor of fused modulation of hedgehog signaling
GENENTECH INC0 citations51
US7144996B1Dec 5, 2006
Nucleic acid encoding human suppressor of fused
GENENTECH INC1 citations51
US10330683B2Jun 25, 2019
Mutant smoothened and methods of using the same
GENENTECH INC0 citations42
US10246515B2Apr 2, 2019
Methods of treating hedgehog-related diseases with an anti-LGR5 antibody
GENENTECH INC0 citations36
EATON DAN L
7 patentsUS8192955B1Jun 5, 2012
Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
EATON DAN L1 citations62
US8178107B1May 15, 2012
Method of treatment of thrombocytopenia or risk thereof using MPL ligand (thrombopoietin), variants, and fragments thereof
EATON DAN L1 citations62
US8399250B1Mar 19, 2013
Anti-mpl ligand (thromobpoietin) antibodies
EATON DAN L0 citations51
US8278099B1Oct 2, 2012
Monoclonal antibody to human thrombopoietin
EATON DAN L0 citations51
US8241900B1Aug 14, 2012
mpl ligand
EATON DAN L0 citations51
US8193323B1Jun 5, 2012
mpl ligand (thrombopoietin), active fragments thereof, and fusion proteins and compositions comprising mpl ligand and other cytokines
EATON DAN L0 citations51
US8147844B1Apr 3, 2012
Mpl ligand (thrombopoietin), nucleic acids encoding such, and methods of treatment using mpl ligand
EATON DAN L0 citations51
DE SAUVAGE FREDERIC J
3 patentsUS8481680B2Jul 9, 2013
Mutant smoothened and methods of using the same
DE SAUVAGE FREDERIC J4 citations57
US8435754B2May 7, 2013
Method of diagnosing the presence of a tumor in a mammal by assessing CDO expression levels
DE SAUVAGE FREDERIC J1 citations50
US9321823B2Apr 26, 2016
Mutant smoothened and methods of using the same
DE SAUVAGE FREDERIC J0 citations43